Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Schistoscope: Towards a locally producible smart diagnostic device for Schistosomiasis in Nigeria

Agbana T, van Young G, Oladepo O, et al. 2019;
Download PDF
Publication

Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia.

Hounsome N, Kassahun M, Ngari M, et al. PLoS neglected tropical diseases. 2019; 13 (10) : e0007780.
Download PDF
Publication

Burden, Drivers, and Impacts of Poor Mental Health in Young People of West and Central Africa: Implications for Research and Programming

Juma K, Wekesah F, Kabiru C, et al. Springer International Publishing. West African Youth Challenges and Opportunity Pathways. 2019;
Download PDF
Publication

Symptom monitoring of childhood illnesses and referrals: A pilot study on the feasibility of a mobile phone-based system as a disease surveillance tool in a rural health district of Ghana.

Mohammed A, Acheampong P, Otupiri E, et al. Health informatics journal. 2019;
Download PDF
Publication

Epidemiological profile and spectrum of neglected tropical disease eumycetoma from Delhi, North India.

Dubey N, Capoor M, Hasan A, et al. Epidemiology and infection. 2019;
Download PDF
Publication

Identifying high risk areas of Zika virus infection by meteorological factors in Colombia.

Chien L, Sy F, Pérez A. BMC infectious diseases. 2019; 19 (1) : 888.
Download PDF
Publication

Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women.

Carlier Y, Altcheh J, Angheben A, et al. PLoS neglected tropical diseases. 2019; 13 (10) : e0007694.
Download PDF
Publication

Optimising the performance of frontline implementers engaged in the NTD programme in Nigeria: lessons for strengthening community health systems for universal health coverage.

Oluwole A, Dean L, Lar L, et al. Human resources for health. 2019; 17 (1) : 79.
Publication

Prevalence and co-infection of schistosomiasis/hepatitis B among rural populations in endemic areas in Hubei, China.

Zhang Y, Xie Y, Chen Q, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2019;
Download PDF
Publication

Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis.

Group N. Gates open research. 2019;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 499
  • Page 500
  • Page 501
  • Page 502
  • Page 503
  • Current page 504
  • Page 505
  • Page 506
  • Page 507
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD